A Delaware judge ruled in early September that J&J did not provide Auris Health with the resources to achieve milestone payments after its 2019 acquisition.
1 month ago

J&J's promise to Auris was broken almost immediately after closing and ordered the company to pay more than $1 billion in damages.
1 month ago

C. auris can be misidentified as a number of different organisms when using traditional phenotypic methods for yeast identification.
3 months ago

Johnson & Johnson owes shareholders of Auris Health $1 billion in damages for breaching a 2019 agreement to acquire the private developer of...
1 month ago

What is C. auris? C. auris, or Candida auris, is a type of yeast that can cause severe illness. It can easily spread among patients in health...
1 month ago

Candida auris is a globally emerged fungal pathogen causing nosocomial invasive infections. Here, we use cutting-edge genomic approaches to...
6 days ago

Candida auris, or C. auris, is a fungus that is highly transmissible and hard to eradicate. It mostly affects patients with severe underlying...
2 months ago

There is ongoing healthcare-associated transmission of C. auris in Washington in at least two facilities; jurisdictions should be aware that there may be...
2 months ago

Johnson & Johnson owes more than $1 billion in damages to investors of robotic surgery device maker Auris Health for breaching earnout provisions in its...
1 month ago

A Delaware judge ruled that Johnson & Johnson must pay $1 billion in damages to Auris Health shareholders, according to media reports.
1 month ago